Channel
@Medical_News_Channel
On this record: Growth · Engagement · Posts · Telegram's recommendations · Cite this entry
3,614subscribers
+6 since we began measuring on 16 August 2026
Risers and fallers across the register · movement among entries of 3,162–10,000.
| Telegram ID | -1001219529479 |
|---|---|
| Type | Channel |
| Username | @Medical_News_Channel |
| Created | 24 January 2020 — measured — cross-checked against a third-party dataset (TGDataset) |
| First recorded | 16 August 2026 |
| Last confirmed live | 6 September 2026 |
| Measurements held | 6 |
| Confirmed unchanged | 2 times, most recently 6 September 2026 |
| On Telegram | t.me/Medical_News_Channel |
| Measured (UTC) | Subscribers | Change |
|---|---|---|
| 2 Sept 2026, 09:54 | 3,614 | +4 |
| 30 Aug 2026, 03:05 | 3,610 | -8 |
| 26 Aug 2026, 20:04 | 3,618 | +2 |
| 20 Aug 2026, 17:35 | 3,616 | +5 |
| 17 Aug 2026, 13:45 | 3,611 | +3 |
| 16 Aug 2026, 17:30 | 3,608 | first reading |
20 posts held, back to 9 July 2026 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 page of Telegram’s post history, 20 posts per page.
ERR is average views per post over the last 30 days divided by subscribers, the definition TGStat uses, so this figure is comparable with the one you will see elsewhere. It falls structurally as a channel grows: a high ERR on a small channel and a low one on a large channel describe reach mathematics, not quality. We publish the figure and the sample it came from and pass no verdict on it.
ER is defined industry-wide as (forwards + reactions + comments) ÷ views — note the denominator is views, not subscribers. Telegram’s public web preview carries views and reactions but not forward or comment counts, so the reaction rate above is the reactions term only and is therefore a floor: the true ER for this channel is higher by an amount we have not measured and will not estimate.
| Window | Rolling 30 days · latest post in window 14 August 2026 |
|---|---|
| Posts held | 20 (9 July 2026 – 14 August 2026) |
| Views total | 92 |
| Reactions total | — |
| Forwards / comments | not exposed by the public surface — not measured, not estimated |
| Readings taken | 16 Aug 2026, 17:30 UTC |
Views are a single reading per post, taken at the time above. A post published in the last day or two is still accumulating views, which pulls the 30-day average down slightly. That is a property of the standard definition rather than a fault in it, so we keep the definition rather than “correcting” the number into something nobody can reproduce.
Precision. Telegram publishes view counts on its public widget in short form — 8.12K, 3.7M — so any reading at or above 1,000 reaches us rounded to three significant figures, and only counts below 1,000 are exact. Averages and rates derived from them are shown to the same precision rather than to the unit: a figure like 3,701,250 would assert digits nobody measured.
Reaction counts are published per emoji and rounded the same way, so a total below 1,000 is exact and a larger one is a sum that may carry a rounded component from each emoji above 1,000. Because it is a sum, it does not look rounded — read a large reaction total as three significant figures per contributing emoji rather than as the figure it prints.
FDA Issues Emergency Use Authorization for Drug to Treat New World Screwworm in Dogs and Puppies http://www.fda.gov/news-events/press-announcements/fda-issues-emergency-use-authorization-drug-treat-new-world-screwworm-dogs-and-puppies
FDA Issues Emergency Use Authorization for Drug to Prevent New World Screwworm in Multiple Species, Including Sheep, Cattle, Goats, and Swine http://www.fda.gov/news-events/press-announcements/fda-issues-emergency-use-authorization-drug-prevent-new-world-screwworm-multiple-species-including
FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma http://www.fda.gov/news-events/press-announcements/fda-approves-new-engineered-viral-immunotherapy-patients-treatment-resistant-advanced-melanoma
FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms http://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-treat-full-range-narcolepsy-type-1-symptoms
FDA Licenses First-Ever Freeze-Dried Plasma Product in the U.S. http://www.fda.gov/news-events/press-announcements/fda-licenses-first-ever-freeze-dried-plasma-product-us
WHO: Integration, innovation and community leadership key to ending HIV, hepatitis and STIs https://www.who.int/news/item/27-07-2026-who--integration--innovation-and-community-leadership-key-to-ending-hiv--hepatitis-and-stis
WHO launches seven strategies to prevent drowning https://www.who.int/news/item/23-07-2026-who-launches-seven-strategies-to-prevent-drowning
FDA Announces First Participant Selected for TEMPO for Digital Health Devices Pilot http://www.fda.gov/news-events/press-announcements/fda-announces-first-participant-selected-tempo-digital-health-devices-pilot
FDA Takes Further Steps to Remove Outdated Authorizations for Color Additives in Food http://www.fda.gov/news-events/press-announcements/fda-takes-further-steps-remove-outdated-authorizations-color-additives-food
UN report: Global hunger levels ease for third consecutive year as regional disparities persist https://www.who.int/news/item/21-07-2026-un-report--global-hunger-levels-ease-for-third-consecutive-year-as-regional-disparities-persist
WHO marks 25 years of Research4Life, advancing access to scientific knowledge in more than 120 countries https://www.who.int/news/item/21-07-2026-who-marks-25-years-of-research4life--advancing-access-to-scientific-knowledge-in-more-than-120-countries
Road deaths fall by 21% globally but stronger action is needed to save lives https://www.who.int/news/item/20-07-2026-road-deaths-fall-by-21--globally-but-stronger-action-is-needed-to-save-lives
Showing the 12 most recent of 20 posts we hold for @Medical_News_Channel. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.
The reverse of the list above, and a different kind of signal. This does not require this channel to have ever been asked about directly — each row below is a channel we DID ask Telegram about, whose Telegram-generated list happened to include this one. A channel can appear here with an empty list above it, because being named by someone else’s query is independent of having been queried itself.
This channel appears in 3 seed channels' Telegram-generated recommendation lists in total. Each is Telegram’s list for THAT channel, not this one — see how this is measured.
A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 2 September 2026 — this entry's latest reading, not the date you are reading this.
“Medical News” (@Medical_News_Channel), 3,614 subscribers as measured 2 September 2026. Telegram Register, tgregister.com/channel/Medical_News_Channel.
Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.